These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36626308)

  • 1. Cerebellar gamma-aminobutyric acid: Investigation of group effects in neurodevelopmental disorders.
    Pang EW; Hammill C; Taylor MJ; Near J; Schachar R; Crosbie J; Arnold PD; Anagnostou E; Lerch JP
    Autism Res; 2023 Mar; 16(3):535-542. PubMed ID: 36626308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Diffusion Tensor Imaging Study in Children With ADHD, Autism Spectrum Disorder, OCD, and Matched Controls: Distinct and Non-Distinct White Matter Disruption and Dimensional Brain-Behavior Relationships.
    Ameis SH; Lerch JP; Taylor MJ; Lee W; Viviano JD; Pipitone J; Nazeri A; Croarkin PE; Voineskos AN; Lai MC; Crosbie J; Brian J; Soreni N; Schachar R; Szatmari P; Arnold PD; Anagnostou E
    Am J Psychiatry; 2016 Dec; 173(12):1213-1222. PubMed ID: 27363509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Magnetic Resonance Spectroscopy Study of Superior Visual Search Abilities in Children with Autism Spectrum Disorder.
    Edmondson DA; Xia P; McNally Keehn R; Dydak U; Keehn B
    Autism Res; 2020 Apr; 13(4):550-562. PubMed ID: 31909886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of anterior cingulate cortex gamma-aminobutyric acid and glutamate-glutamine levels in obsessive-compulsive disorder using magnetic resonance spectroscopy.
    Li Y; Zhang CC; Kathrin Weidacker ; Zhang Y; He N; Jin H; Chen W; Voon V; Edden RAE; Yan F
    BMC Psychiatry; 2019 May; 19(1):164. PubMed ID: 31146727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder.
    Pretzsch CM; Freyberg J; Voinescu B; Lythgoe D; Horder J; Mendez MA; Wichers R; Ajram L; Ivin G; Heasman M; Edden RAE; Williams S; Murphy DGM; Daly E; McAlonan GM
    Neuropsychopharmacology; 2019 Jul; 44(8):1398-1405. PubMed ID: 30758329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcortical Brain Volume, Regional Cortical Thickness, and Cortical Surface Area Across Disorders: Findings From the ENIGMA ADHD, ASD, and OCD Working Groups.
    Boedhoe PSW; van Rooij D; Hoogman M; Twisk JWR; Schmaal L; Abe Y; Alonso P; Ameis SH; Anikin A; Anticevic A; Arango C; Arnold PD; Asherson P; Assogna F; Auzias G; Banaschewski T; Baranov A; Batistuzzo MC; Baumeister S; Baur-Streubel R; Behrmann M; Bellgrove MA; Benedetti F; Beucke JC; Biederman J; Bollettini I; Bose A; Bralten J; Bramati IE; Brandeis D; Brem S; Brennan BP; Busatto GF; Calderoni S; Calvo A; Calvo R; Castellanos FX; Cercignani M; Chaim-Avancini TM; Chantiluke KC; Cheng Y; Cho KIK; Christakou A; Coghill D; Conzelmann A; Cubillo AI; Dale AM; Dallaspezia S; Daly E; Denys D; Deruelle C; Di Martino A; Dinstein I; Doyle AE; Durston S; Earl EA; Ecker C; Ehrlich S; Ely BA; Epstein JN; Ethofer T; Fair DA; Fallgatter AJ; Faraone SV; Fedor J; Feng X; Feusner JD; Fitzgerald J; Fitzgerald KD; Fouche JP; Freitag CM; Fridgeirsson EA; Frodl T; Gabel MC; Gallagher L; Gogberashvili T; Gori I; Gruner P; Gürsel DA; Haar S; Haavik J; Hall GB; Harrison NA; Hartman CA; Heslenfeld DJ; Hirano Y; Hoekstra PJ; Hoexter MQ; Hohmann S; Høvik MF; Hu H; Huyser C; Jahanshad N; Jalbrzikowski M; James A; Janssen J; Jaspers-Fayer F; Jernigan TL; Kapilushniy D; Kardatzki B; Karkashadze G; Kathmann N; Kaufmann C; Kelly C; Khadka S; King JA; Koch K; Kohls G; Konrad K; Kuno M; Kuntsi J; Kvale G; Kwon JS; Lázaro L; Lera-Miguel S; Lesch KP; Hoekstra L; Liu Y; Lochner C; Louza MR; Luna B; Lundervold AJ; Malpas CB; Marques P; Marsh R; Martínez-Zalacaín I; Mataix-Cols D; Mattos P; McCarthy H; McGrath J; Mehta MA; Menchón JM; Mennes M; Martinho MM; Moreira PS; Morer A; Morgado P; Muratori F; Murphy CM; Murphy DGM; Nakagawa A; Nakamae T; Nakao T; Namazova-Baranova L; Narayanaswamy JC; Nicolau R; Nigg JT; Novotny SE; Nurmi EL; Weiss EO; O'Gorman Tuura RL; O'Hearn K; O'Neill J; Oosterlaan J; Oranje B; Paloyelis Y; Parellada M; Pauli P; Perriello C; Piacentini J; Piras F; Piras F; Plessen KJ; Puig O; Ramos-Quiroga JA; Reddy YCJ; Reif A; Reneman L; Retico A; Rosa PGP; Rubia K; Rus OG; Sakai Y; Schrantee A; Schwarz L; Schweren LJS; Seitz J; Shaw P; Shook D; Silk TJ; Simpson HB; Skokauskas N; Soliva Vila JC; Solovieva A; Soreni N; Soriano-Mas C; Spalletta G; Stern ER; Stevens MC; Stewart SE; Sudre G; Szeszko PR; Tamm L; Taylor MJ; Tolin DF; Tosetti M; Tovar-Moll F; Tsuchiyagaito A; van Erp TGM; van Wingen GA; Vance A; Venkatasubramanian G; Vilarroya O; Vives-Gilabert Y; von Polier GG; Walitza S; Wallace GL; Wang Z; Wolfers T; Yoncheva YN; Yun JY; Zanetti MV; Zhou F; Ziegler GC; Zierhut KC; Zwiers MP; ; ; ; Thompson PM; Stein DJ; Buitelaar J; Franke B; van den Heuvel OA
    Am J Psychiatry; 2020 Sep; 177(9):834-843. PubMed ID: 32539527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamatergic and GABAergic gene sets in attention-deficit/hyperactivity disorder: association to overlapping traits in ADHD and autism.
    Naaijen J; Bralten J; Poelmans G; ; Glennon JC; Franke B; Buitelaar JK
    Transl Psychiatry; 2017 Jan; 7(1):e999. PubMed ID: 28072412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentrations of Cortical GABA and Glutamate in Young Adults With Autism Spectrum Disorder.
    Kolodny T; Schallmo MP; Gerdts J; Edden RAE; Bernier RA; Murray SO
    Autism Res; 2020 Jul; 13(7):1111-1129. PubMed ID: 32297709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy.
    Simpson HB; Shungu DC; Bender J; Mao X; Xu X; Slifstein M; Kegeles LS
    Neuropsychopharmacology; 2012 Nov; 37(12):2684-92. PubMed ID: 22850733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory Dysfunction in Neurodevelopmental Disorders: A Meta-analytic Review of Autism Spectrum Disorders, Attention Deficit/Hyperactivity Disorder and Obsessive-Compulsive Disorder.
    Crow AJD; Janssen JM; Vickers KL; Parish-Morris J; Moberg PJ; Roalf DR
    J Autism Dev Disord; 2020 Aug; 50(8):2685-2697. PubMed ID: 31960263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cannabidivarin (CBDV) on brain excitation and inhibition systems in adults with and without Autism Spectrum Disorder (ASD): a single dose trial during magnetic resonance spectroscopy.
    Pretzsch CM; Voinescu B; Lythgoe D; Horder J; Mendez MA; Wichers R; Ajram L; Ivin G; Heasman M; Edden RAE; Williams S; Murphy DGM; Daly E; McAlonan GM
    Transl Psychiatry; 2019 Nov; 9(1):313. PubMed ID: 31748505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the relationship between cortical GABA concentrations, auditory gamma-band responses and development in ASD: Evidence for an altered maturational trajectory in ASD.
    Port RG; Gaetz W; Bloy L; Wang DJ; Blaskey L; Kuschner ES; Levy SE; Brodkin ES; Roberts TPL
    Autism Res; 2017 Apr; 10(4):593-607. PubMed ID: 27696740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased prefrontal GABA concentrations in adults with autism spectrum disorders.
    Maier S; Düppers AL; Runge K; Dacko M; Lange T; Fangmeier T; Riedel A; Ebert D; Endres D; Domschke K; Perlov E; Nickel K; Tebartz van Elst L
    Autism Res; 2022 Jul; 15(7):1222-1236. PubMed ID: 35587691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autism Spectrum Symptoms in a Tourette's Disorder Sample.
    Darrow SM; Grados M; Sandor P; Hirschtritt ME; Illmann C; Osiecki L; Dion Y; King R; Pauls D; Budman CL; Cath DC; Greenberg E; Lyon GJ; McMahon WM; Lee PC; Delucchi KL; Scharf JM; Mathews CA
    J Am Acad Child Adolesc Psychiatry; 2017 Jul; 56(7):610-617.e1. PubMed ID: 28647013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Size anomaly and alteration of GABAergic enzymes expressions in cerebellum of a valproic acid mouse model of autism.
    Ma SY; Kwan KM
    Behav Brain Res; 2022 Jun; 428():113896. PubMed ID: 35436531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental changes in gamma-aminobutyric acid levels in attention-deficit/hyperactivity disorder.
    Bollmann S; Ghisleni C; Poil SS; Martin E; Ball J; Eich-Höchli D; Edden RA; Klaver P; Michels L; Brandeis D; O'Gorman RL
    Transl Psychiatry; 2015 Jun; 5(6):e589. PubMed ID: 26101852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodevelopmental disorders and comorbidity in young adults attending a psychiatric outpatient clinic.
    Eberhard D; Billstedt E; Gillberg C
    Psychiatry Res; 2022 Jul; 313():114638. PubMed ID: 35597136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical versus automated assessments of morphological variants in twins with and without neurodevelopmental disorders.
    Myers L; Anderlid BM; Nordgren A; Lundin K; Kuja-Halkola R; Tammimies K; Bölte S
    Am J Med Genet A; 2020 May; 182(5):1177-1189. PubMed ID: 32162839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emotional face processing across neurodevelopmental disorders: a dynamic faces study in children with autism spectrum disorder, attention deficit hyperactivity disorder and obsessive-compulsive disorder.
    Vandewouw MM; Choi E; Hammill C; Arnold P; Schachar R; Lerch JP; Anagnostou E; Taylor MJ
    Transl Psychiatry; 2020 Nov; 10(1):375. PubMed ID: 33139709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADGRL3 rs6551665 as a Common Vulnerability Factor Underlying Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder.
    Kappel DB; Schuch JB; Rovaris DL; da Silva BS; Müller D; Breda V; Teche SP; S Riesgo R; Schüler-Faccini L; Rohde LA; Grevet EH; Bau CHD
    Neuromolecular Med; 2019 Mar; 21(1):60-67. PubMed ID: 30652248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.